Pfizer seeks to expand omicron booster to 5- to 11-year-olds

United States News News

Pfizer seeks to expand omicron booster to 5- to 11-year-olds
United States Latest News,United States Headlines
  • 📰 KPRC2
  • ⏱ Reading Time:
  • 18 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 68%

Pfizer is asking the Food and Drug Administration to expand use of its updated COVID-19 booster shot to children ages 5 to 11. pfizer booster kprc2 click2houston vaccine

FILE - A Jackson, Miss., resident receives a Pfizer booster shot from a nurse at a vaccination site Feb. 8, 2022. Pfizer is asking the Food and Drug Administration to expand use of its updated COVID-19 booster shot to children ages 5 to 11, Monday, Sept. 26. Already 4.4 million Americans have received one of the updated boosters since they rolled out earlier this month for anyone 12 and older. to children ages 5 to 11.

If the Food and Drug Administration agrees, they would start getting a kid-sized dose of the new omicron-targeted formula when it is time for their booster. Pfizer and its partner BioNTech also announced a new study of the omicron-focused booster in even younger children, those ages 6 months through 4 years, to test different doses.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

KPRC2 /  🏆 80. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Pfizer seeks to expand omicron booster to 5- to 11-year-oldsPfizer seeks to expand omicron booster to 5- to 11-year-oldsPfizer is asking the Food and Drug Administration to expand use of its updated COVID-19 booster shot to children ages 5 to 11.
Read more »

Pfizer seeks to expand omicron booster to 5- to 11-year-oldsPfizer seeks to expand omicron booster to 5- to 11-year-oldsIf the Food and Drug Administration agrees, they would start getting a kid-sized dose of the new omicron-targeted formula when it was time for their booster.
Read more »

Pfizer CEO tests positive for COVID for a second timePfizer CEO tests positive for COVID for a second timeAlbert Bourla had contacted the virus in August and took a course of the company's oral COVID-19 antiviral treatment, Paxlovid. He said he has not yet taken the new bivalent booster.
Read more »

Pfizer CEO tests positive for COVID-19 for second time in two monthsPfizer CEO tests positive for COVID-19 for second time in two monthsPfizer CEO Albert Bourla announced Saturday that he tested positive for COVID-19 — again.
Read more »

Pfizer seeks to expand COVID omicron booster to 5- to 11-year-oldsPfizer seeks to expand COVID omicron booster to 5- to 11-year-oldsIf the FDA agrees, children would start getting a kid-sized dose of the new omicron-targeted formula.
Read more »

Bivalent booster: Pfizer seeks to expand shot to 5- to 11-year-oldsBivalent booster: Pfizer seeks to expand shot to 5- to 11-year-oldsPfizer is asking the FDA to expand use of its updated COVID-19 vaccine booster shot to children ages 5 to 11. The so-called bivalent shot is meant to be more effective against omicron variants of the coronavirus.
Read more »



Render Time: 2025-02-23 14:02:55